In a meta-analysis published in 2011, comprising 20 previous publications, Westlakeet al. summarized the potential effects of anti-TNF-α inpatients with psoriatic arthritis not only on MACE (including heart failure), butalso on the risk of developing cardiovascular disease again. This evidence concerns the gene TNF and cardiovascular disorder.